Weidong Zhang

3.0k total citations
86 papers, 2.0k citations indexed

About

Weidong Zhang is a scholar working on Molecular Biology, Organic Chemistry and Complementary and alternative medicine. According to data from OpenAlex, Weidong Zhang has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 17 papers in Organic Chemistry and 15 papers in Complementary and alternative medicine. Recurrent topics in Weidong Zhang's work include Traditional Chinese Medicine Analysis (10 papers), Metabolomics and Mass Spectrometry Studies (9 papers) and Pharmacological Effects of Natural Compounds (7 papers). Weidong Zhang is often cited by papers focused on Traditional Chinese Medicine Analysis (10 papers), Metabolomics and Mass Spectrometry Studies (9 papers) and Pharmacological Effects of Natural Compounds (7 papers). Weidong Zhang collaborates with scholars based in China, United States and United Kingdom. Weidong Zhang's co-authors include Xin Luan, Xiang Li, Honggang Hu, Si Chen, Hongzhuan Chen, Yi Qu, Xisong Ke, Yudong Zhou, Yiwen Shen and Sai Tian and has published in prestigious journals such as Science, Chemical Reviews and Angewandte Chemie International Edition.

In The Last Decade

Weidong Zhang

80 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weidong Zhang China 25 1.2k 320 286 203 200 86 2.0k
Hye Jin Jung South Korea 26 1.3k 1.1× 217 0.7× 245 0.9× 116 0.6× 167 0.8× 118 2.3k
Jo‐Hua Chiang Taiwan 31 1.3k 1.1× 222 0.7× 286 1.0× 160 0.8× 209 1.0× 56 2.3k
Nan Ma China 20 825 0.7× 361 1.1× 287 1.0× 112 0.6× 180 0.9× 90 1.7k
Likun Gong China 24 541 0.5× 115 0.4× 285 1.0× 124 0.6× 348 1.7× 89 1.5k
Nam Doo Kim South Korea 32 1.8k 1.6× 454 1.4× 384 1.3× 64 0.3× 161 0.8× 102 2.9k
Kuang‐Chi Lai Taiwan 33 1.5k 1.3× 216 0.7× 373 1.3× 157 0.8× 325 1.6× 70 2.8k
Fayaz Malik India 28 1.2k 1.1× 268 0.8× 551 1.9× 399 2.0× 146 0.7× 77 2.7k
Anindya Goswami India 25 1.2k 1.1× 272 0.8× 365 1.3× 135 0.7× 72 0.4× 83 1.9k
Jung‐Il Chae South Korea 29 1.3k 1.1× 174 0.5× 250 0.9× 85 0.4× 345 1.7× 84 2.1k
Lianxiang Luo China 27 1.3k 1.1× 115 0.4× 279 1.0× 103 0.5× 175 0.9× 138 2.5k

Countries citing papers authored by Weidong Zhang

Since Specialization
Citations

This map shows the geographic impact of Weidong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong Zhang more than expected).

Fields of papers citing papers by Weidong Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weidong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong Zhang. The network helps show where Weidong Zhang may publish in the future.

Co-authorship network of co-authors of Weidong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Weidong Zhang. A scholar is included among the top collaborators of Weidong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weidong Zhang. Weidong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jinxin, et al.. (2025). Artificial farnesol epoxidase enables a concise synthesis of meroterpenoids. Science. 389(6761). 732–735.
2.
Zhang, Weidong, et al.. (2025). The Transmission of Herbal Medicine to China via the Silk Road in Medieval Ages. SHILAP Revista de lepidopterología. 8(1). 13–23.
3.
Hu, Hongmei, Mengting Xu, Mengmeng Guo, et al.. (2025). Cordycepin Targets HRD1 to Promote Cancer Cell PD‐L1 Ubiquitin–Proteasome Degradation and Increase Antitumor Immunity. MedComm. 6(11). e70430–e70430.
4.
Lin, Jiayi, Ye Wu, Min Tang, et al.. (2025). A Self‐Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple‐Negative Breast Cancer Therapy. Advanced Science. 12(23). e2500311–e2500311. 3 indexed citations
5.
Wu, Gaosong, Yuhao Zhang, Jing Zhao, et al.. (2024). Shexiang Baoxin Pill enriches Lactobacillus to regulate purine metabolism in patients with stable coronary artery disease. Phytomedicine. 130. 155727–155727. 1 indexed citations
6.
Shen, Yiwen, Beibei Zhang, Jing Zhang, et al.. (2024). Integrating single‐cell and spatial analysis reveals MUC1‐mediated cellular crosstalk in mucinous colorectal adenocarcinoma. Clinical and Translational Medicine. 14(5). e1701–e1701. 11 indexed citations
7.
Chen, Hong, et al.. (2024). Photo-mediated radical relay oximinosulfonamidation of alkenes with N-nitrosamines triggered by DABSO. Green Chemistry. 26(13). 7849–7856. 11 indexed citations
8.
Tian, Sai, X. Charlene Liao, Jinyuan Lu, et al.. (2024). GSFM: A genome-scale functional module transformation to represent drug efficacy for in silico drug discovery. Acta Pharmaceutica Sinica B. 15(1). 133–150. 2 indexed citations
9.
Liang, Xiaohui, Lu Dong, Jiayi Lin, et al.. (2024). In Silico Discovery of Stapled Peptide Inhibitor Targeting the Nur77‐PPARγ Interaction and Its Anti‐Breast‐Cancer Efficacy. Advanced Science. 11(26). e2308435–e2308435. 7 indexed citations
10.
Zhang, Yu, Qiannan Li, Ping Wang, et al.. (2024). A visible-light-promoted metal-free approach for N–H insertions by using donor/donor diazo precursors. Green Chemistry. 26(8). 4600–4608. 13 indexed citations
11.
Hu, Hongmei, Qun Wang, Xiaoyu Tao, et al.. (2024). Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual‐Targeting BMI1 for Senescence Induction and CSN5 for PD‐L1 Degradation. Advanced Science. 12(7). e2413122–e2413122. 7 indexed citations
12.
Li, Qiannan, et al.. (2023). Uranyl nitrate as a recyclable homogeneous photocatalyst for selective cross-coupling of N-substituted amines and indoles. RSC Advances. 13(18). 11929–11937. 6 indexed citations
13.
Lin, Jiayi, Haijun Liu, Ye Wu, et al.. (2023). Targeted Protein Degradation Technology and Nanomedicine: Powerful Allies against Cancer. Small. 19(18). e2207778–e2207778. 24 indexed citations
14.
Wu, Rong-Kai, Jinxin Wang, Xinyu Han, et al.. (2023). Visible-Light-Mediated Energy Transfer Enables Cyclopropanes Bearing Contiguous All-Carbon Quaternary Centers. ACS Catalysis. 13(14). 9806–9816. 46 indexed citations
15.
Zhang, Wendan, Honghong Jiang, Gaosong Wu, et al.. (2023). The pathogenesis and potential therapeutic targets in sepsis. SHILAP Revista de lepidopterología. 4(6). 38 indexed citations
16.
Tian, Sai, Jinbo Zhang, Shunling Yuan, et al.. (2023). Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM. Briefings in Bioinformatics. 24(2). 60 indexed citations
17.
Zhang, Zhen, et al.. (2022). G3BP2: Structure and function. Pharmacological Research. 186. 106548–106548. 25 indexed citations
18.
Wu, Ye, Lu Dong, Yixin Jiang, et al.. (2021). Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma. Journal of Medicinal Chemistry. 64(9). 5802–5815. 37 indexed citations
19.
Shen, Yiwen, Yudong Zhou, Hongzhuan Chen, Xin Luan, & Weidong Zhang. (2020). Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity. Trends in cancer. 7(6). 511–524. 74 indexed citations
20.
Zhang, Weidong, et al.. (2016). MICROBIOTA OF SHELL-BORING CONCHOCELIS OF PYROPIA YEZOENSIS DETERMINED BY THE NEXT-GENERATION SEQUENCING. 47(5). 996. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hye Jin Jung Breakdown of academic impact, for papers by Jo‐Hua Chiang Breakdown of academic impact, for papers by Nan Ma Breakdown of academic impact, for papers by Likun Gong Breakdown of academic impact, for papers by Nam Doo Kim Breakdown of academic impact, for papers by Kuang‐Chi Lai Breakdown of academic impact, for papers by Fayaz Malik Breakdown of academic impact, for papers by Anindya Goswami Breakdown of academic impact, for papers by Jung‐Il Chae Breakdown of academic impact, for papers by Lianxiang Luo
Rankless by CCL
2026